APA (7th ed.) Citation

Y, N., K, K., T, I., D, T., Y, W., T, K., . . . S, R. (2026). Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis. Arthritis research & therapy, 28(1), 32. https://doi.org/10.1186/s13075-025-03722-5

Chicago Style (17th ed.) Citation

Y, Nozaki, et al. "Real-world Comparative Effectiveness of Sarilumab Versus Janus Kinase Inhibitors as Monotherapy in Rheumatoid Arthritis." Arthritis Research & Therapy 28, no. 1 (2026): 32. https://doi.org/10.1186/s13075-025-03722-5.

MLA (9th ed.) Citation

Y, Nozaki, et al. "Real-world Comparative Effectiveness of Sarilumab Versus Janus Kinase Inhibitors as Monotherapy in Rheumatoid Arthritis." Arthritis Research & Therapy, vol. 28, no. 1, 2026, p. 32, https://doi.org/10.1186/s13075-025-03722-5.